TP53 and cancer: In a compilation of survival analysis of several cancer types, including CRC, from a combined dataset of The Cancer Genome Atlas (TCGA) and MSKCC bladder cancer dataset (JCO, 2013), totaling 2916 cases, Xu et al. [89] examined how individual p53 hotspot mutations affect outcomes in human cancer.